MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Saturday, March 3, 2018

Study uncovers potential risks of common MS treatment

In one of the most comprehensive studies to date, University of British Columbia researchers found an increased risk of events such as stroke, migraine, and depression, as well as abnormalities in the blood with taking beta interferon for multiple sclerosis. Researchers hope their study will lead to further research to develop biomarkers to help identify patients who are at the greatest risk of having an adverse event.

The study’s authors aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting MS by analyzing health records of more than 2,000 British Columbians with MS between 1995 and 2008.

The researchers found a 1.8-fold increased risk of stroke, a 1.6-fold increased risk of migraine, and a 1.3-fold increased risk of both depression and abnormalities in the blood. The researchers stress that patients and physicians should not change their treatment plans. The study is based on population-level data and the risk to individual patients will vary greatly depending on individual factors.

Read more


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
MS Views and News provides Multiple Sclerosis education, information, resources and services that will benefit many affected by MS. 
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Friday, March 2, 2018

FDA approves Glatopa 40 mg/mL generic option for relapsing MS

Feb 2018

Sandoz announced the FDA approval and launch of Glatopa (glatiramer acetate injection) 40 mg/mL. Glatopa 40 mg/mL is a fully-substitutable, AP-rated generic version of Copaxone 40 mg/mL three times-a-week therapy for relapsing forms of multiple sclerosis.

Glatopa 40 mg/mL, along with Glatopa 20 mg/mL, will offer patients a complete range of dosing options. Glatopa 20 mg/mL was made available in the U.S. in June 2015. Patients can expect the same patient services for Glatopa 40 mg/mL as for Glatopa 20 mg/mL.

Sandoz GlatopaCare will offer a $0 co-pay support program to qualified patients. To help increase patient confidence with administering injections, patients will receive personalized injection training, 24-hour access to nurses for Glatopa-related questions and a free starter kit, which includes the Glatopaject injection device, designed to work with both Glatopa 20 mg/mL and 40 mg/mL prefilled syringes.



::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

What is optic neuritis in MS?

When you have optic neuritis, the nerve that sends messages from your eye to your brain, called the optic nerve, is inflamed.
It can happen all of a sudden. Your vision gets dim or blurry. You can’t see colors. Your eyeshurt when you move them. It’s a common problem for people living with multiple sclerosis(MS). The symptoms can seem scary, but most people recover fully, often without treatment.

What Is Optic Neuritis?

We don’t know why, but sometimes your immune systemattacks the fatty coating called myelin that covers and protects your optic nerve. When the myelin is damaged or missing, your optic nerve can't send the right signals to your brain. This can lead to changes in your vision.
Optic neuritis is one of the most common symptoms of the relapsing-remitting form of MS. But it can also happen when you take certain medications or if you have diabetes. It’s also linked to neuromyelitis optica(NMO), or Devic's disease. This autoimmune disorder causes immune system cells and antibodies to attack your optic nerves, spinal cord, and, sometimes, your brain.

Symptoms of Optic Neuritis

This condition usually comes on quickly, over a few hours or days. You may notice some of these symptoms:
  • Pain when you move your eyes
  • Blurred vision
  • Loss of color vision
  • Trouble seeing to the side
  • A hole in the center of your vision
  • Blindness in rare cases
  • Headache -- a dull ache behind your eyes
Adults usually get optic neuritis in only one eye, but children may have it in both.
Some people get better in a few weeks, even without treatment. For others, it can take up to a year. And a few people never fully regain their sight. Even when other symptoms clear up, they may still have trouble with night vision or seeing colors.



::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
MS Views and News provides Multiple Sclerosis education, information, resources and services that will benefit many affected by MS. 
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

When Someone You Love Has Multiple Sclerosis

For decades, #DaveBexfield, who's had multiple sclerosis (MS) since 2005, was the designated "bug killer" in his house. When his wife, Laura, spotted a spider or cricket, Dave came to the rescue.
But one day, when Dave was cleaning up a dead spider, he fell -- and landed in the emergency room. The couple quickly realized that Laura, Dave's primary caregiver, needed to take on more household tasks.
Dave and Laura, who live in Albuquerque, NM, now tag-team on home chores. Dave uses a walker or wheelchair, and forearm crutches, so he does sitting-down tasks, while Laura does others.
"He loads the dishwasher and I put the clean dishes away. He folds the laundry and I hang it in the closet."
It's all part of the adjustment that comes with taking a bigger role in your loved one's care. Some simple changes can make the transition go easier.

Tips for the Caregiver

Help with daily living. Expect to take on more everyday tasks. You may need to arrange transportation and run errands for your loved one. Household chores like cleaning, cooking, shopping, laundry, and child care may shift.
Depending on your loved one's MS symptoms, you may have to help with basic care like dressing, feeding, toileting, and bathing.
Make adjustments at home. Helping your loved one to be more independent is good for both of you. You may need to do some research on equipment like a walker or wheelchair.
Take stock of your house. Ramps, wider doorways, and bathroom equipment help him stay safe and make it easier to get around. An occupational or physical therapist can come to your home to suggest specific changes.
Promote a healthy lifestyle. "A lot of people with MS are trying to improve their diet. As a caregiver, you can step in and join them," says Victoria Leavitt, PhD, a neuropsychologist at Columbia University Medical Center in New York.


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Breaking News: MS Drug Daclizumab Pulled from Worldwide Market

by  Contributing Writer, MedPage Today
Biogen and Abbvie voluntarily pulled the multiple sclerosis drug daclizumab (Zinbryta) from the worldwide market today, following reports of inflammatory encephalitis and meningoencephalitis in patients in Europe.


The European Medicines Agency (EMA) started an urgent review of the drug after seven cases of serious inflammatory brain disorders in Germany -- including encephalitis and meningoencephalitis -- and one case in Spain were reported.

Daclizumab is a self-administered, under-the-skin injection for relapsing forms of multiple sclerosis. In the United States, the FDA approved the drug in 2016 with a boxed warning that the product could cause severe liver injury, including life-threatening and fatal events. These risks prompted the FDA to caution that daclizumab should be used only in patients who had failed to respond to one or two prior therapies.

The drug targets the α-chain of the interleukin-2 receptor CD25. In the phase III DECIDE trial, daclizumab reduced relapse rates and disability progression more effectively than interferon beta-1a (Avonex), but the liver toxicity that had been seen in earlier studies remained a problem. In the phase II SELECTION trial, one patient died from autoimmune hepatitis and two others developed autoimmune conditions affecting vital organs.

"This news is not surprising," Mark Freedman, MD, of the University of Ottawa, told MedPage Today. "There are so many other better drugs available that many of us had a hard time positioning it in our MS armamentarium."


         


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Thursday, March 1, 2018

FOR THOSE WITH RELAPSING-REMITTING MS, HERE IS A CLINICAL TRIAL TO LEARN ABOUT


FOR THOSE WITH RELAPSING-REMITTING MS,
HERE IS A CLINICAL TRIAL TO LEARN ABOUT

Do you have relapsing-remitting multiple sclerosis (RRMS)? If so, you can help put MS to the test by joining EVOLVE-MS-2, a clinical trial that’s being conducted in your area.

This is your opportunity to be involved in the research and development of a new investigational drug for RRMS. Eligible participants will meet with study doctors, and receive the investigational drug and study-related care – all at no cost to you.

If you have RRMS and are looking to take part in clinical research for a new potential treatment of RRMS, learn more about the EVOLVE-MS-2 trial.


To learn more, visit www.evolve-ms.us  today.
And help us put MS to the test.


==============================================

SUBSCRIBE to our MS Learning Channel on YouTube:
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Celebrate Your Support Partners This March



Join us to thank the support partners who help empower the MS community! During Multiple Sclerosis (MS) Awareness Month, MS Views & News is excited to be working with Biogen and other MS organizations on #MySupportHero – a way to celebrate those who support us in our journey with MS, be it family, friends or healthcare professionals.

Want to get involved? Here’s how:
  • Recognize your support partner(s) on social media using the #MySupportHero hashtag, and consider posting a photo or short video honoring this special person in your life
Update your social media profile photo with our official #MySupportHero virtual flower symbolizing your support partner appreciation - 

·       Share #MySupportHero posts from Above MS and MS Views & News Facebook pages

·       Retweet #MySupportHero posts from @BiogenMS and @MSViews_andNews

·       Visit AboveMS.com to download the official #MySupportHero virtual flower and replace your social media profile picture with this image to symbolize your support partner appreciation

Learn more about #MySupportHero and how we’re celebrating support heroes who help the community rise above MS.

Note: Biogen does not have any involvement with content unrelated to #MySupportHero on MS Views & News’ website and social media pages.
###



Wednesday, February 28, 2018

video: A Look at the Invisible Symptoms of #MS - with Brian Steingo, MD

REALLY? – But You Look SO GOOD! A look at the Invisible Symptoms of #MS Treatment Options, Adherence, Compliance, and Primary Symptoms that cause dysfunction



::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Video: Urinary Incontinence PLUS Neuro-Psychological Testing for Multiple Sclerosis



2014 Neurological Aspects of Multiple Sclerosis - MS Symposium Central Florida - Part 2 Bladder Issues and Neuro-Psychological Testing information - Christopher Walker, MD To speak about Bladder Issues with MS -
and Justin Koenitzer, PsyD., To Speak about Neuro-Psych testing for Disability Claims
Plus a Q&A



SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Video: What Causes Multiple Sclerosis and Will There Ever Be a Cure?

Published - Dec 2017

Dr. Daniel Kantor speaks with Dr. Mark Gudesplatt, Dr. Regina Berkovich,
Dr. Samuel Hunter, Dr. Augusto Miravalle and Dr. Edward Fox
about what causes Multiple Sclerosis and if there will ever be a cure.




an MS World Video


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Study in mice suggests personalized stem cell treatment may offer relief for MS

PUBLIC RELEASE: 22-FEB-2018
UNIVERSITY OF CAMBRIDGE

Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).

The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatment based on a patient's own skin cells for diseases of the central nervous system (CNS).

In MS, the body's own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.

Key immune cells involved in causing this damage are macrophages (literally 'big eaters'), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord - in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.

Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body's 'master cells', which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) - stem cells that are part-way to developing into nerve cells - reduces inflammation and can help the injured CNS heal.

However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.

A possible solution to this problem would be the use of so-called 'induced neural stem cells (iNSCs)' - these cells can be generated by taking an adult's skin cells and 're-programming' them back to become neural stem cells. As these iNSCs would be the patient's own, they are less likely to trigger an immune response.

Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.

Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.

Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia - in essence, turning 'bad' immune cells 'good'. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.

"Our mouse study suggests that using a patient's reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS," says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.

"This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response."

The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.

Continue


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Video: Ben Thrower, M.D. - Cell Based Therapies in MS - November 2017


Dr. Ben Thrower discusses the various types of cell based therapies, their pros and cons, and what is on the horizon for MS.



 Video was produced by MS Focus


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Video: Multiple Sclerosis and MRI: T1 Black Holes, Brain Atrophy & Progression


Certain markers on the MRI teach us about progression of disease. These include T1 hypo-intensities (aka T1 black holes) and accelerated rates of brain atrophy (aka faster rates of brain shrinkage). In this video we review real MRI images of T1 black holes and discuss their significance. We show also discuss MRI images of accelerated brain shrinkage and discuss their significance in MS. Of note, we have selected severe examples. We also discuss the use of emerging technologies to be able to start to measure and track rates of brain atrophy IN CLINIC. We use a software package that processes a volume analysis of the brain (and it's parts) and compares them to age/gender matches controls. This allows us to better understand THAT individuals degree of atrophy and track it's change over time. Current software isn't perfect, but it provides a very helpful guide to better inform our decisions in clinic.


=====================================================


SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

video: Multiple Sclerosis and the MRI: What is an MRI? How does an MRI work?



Produced by Aaron Boster, MD



::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

video: Sleep Hygiene in Multiple Sclerosis




::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
MS Views and News provides Multiple Sclerosis education, information, resources and services that will benefit many affected by MS. 
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Tuesday, February 27, 2018

'Magnet Therapy' May Be Effective in Treating MS Symptoms



Evidence is showing that magnet therapy could be the answer to treating many symptoms of multiple sclerosis (MS).
Those are the findings of researchers who published a study in October, in the journal Clinical Neurology and Neurosurgery, on the benefits of pulsing magnetic fields on a common presenting symptom of MS — paresthesia, commonly known as “pins and needles.”  
The concept of magnets as healing devices dates back to 3,000 B.C., according to the Magnetic Therapy Council.
Magnets have been used around the world. Now, researchers say scientific findings are backing up this ancient method of healing.
Those are the findings of researchers who published a study in October, in the journal Clinical Neurology and Neurosurgery, on the benefits of pulsing magnetic fields on a common presenting symptom of MS — paresthesia, commonly known as “pins and needles.”  
The concept of magnets as healing devices dates back to 3,000 B.C., according to the Magnetic Therapy Council.
Magnets have been used around the world. Now, researchers say scientific findings are backing up this ancient method of healing.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

MS Views and News is MAKING an IMPACT for those, affected by Multiple Sclerosis
SUBSCRIBE to our MS Learning Channel on YouTube: www.youtube.com/msviewsandnews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::